Care View Communications Inc CRVW
We take great care to ensure that the data presented and summarized in this overview for CareView Communications Inc is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in CRVW
Top Purchases
Top Sells
About CRVW
CareView Communications, Inc. provides monitoring solutions for the healthcare industry in the United States. The company provides CareView Patient Safety System, a video monitoring tool to improve the practice of nursing, create a better work environment, and make the patient's hospital stay more satisfying, which is used in hospitals, nursing homes, adult living centers, and outpatient care facilities; and Caregiver Platform, which offers caregiver connect mobile application to provide a convenient and intuitive interface to capture critical workflows, such as acknowledging and documenting alert presses by the resident. It also offers CareView Connect, which provides resident monitoring products and services for the long- term care industry; an array of wearable and stationary buttons that allow a resident to summon help either for an emergency or assistance; a mobile app capable of delivering an alert to the caregiver and allows them document information around that alert; and alert management and monitoring system. In additions, it also provides SitterView and TeleMedView allows hospital staff to use CareView's video cameras to observe and communicate with patients remotely. CareView Communications, Inc. was founded in 1997 and is based in Lewisville, Texas.
Insider Transactions at CRVW
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 24
2023
|
Health Cor Associates, LLC Director |
BUY
Conversion of derivative security
|
Indirect |
180,000,000
+33.33%
|
$0
$0.1 P/Share
|
May 24
2023
|
Health Cor Management, L.P. Director |
BUY
Conversion of derivative security
|
Indirect |
180,000,000
+33.33%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
Health Cor Associates, LLC Director |
BUY
Conversion of derivative security
|
Indirect |
207,641,660
+50.0%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
Health Cor Management, L.P. Director |
BUY
Conversion of derivative security
|
Indirect |
207,641,660
+50.0%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
L. Allen Wheeler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
800,000
+6.57%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
Jeffrey C Lightcap Director |
SELL
Exercise of conversion of derivative security
|
Indirect |
7,000,000
-50.0%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
Jeffrey C Lightcap Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,500,000
+48.15%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
Sandra K Mc Ree Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,000,000
+50.0%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
Sandra K Mc Ree Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000,000
+36.36%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
Steven G. Johnson President/CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,500,000
+49.01%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
Jason T Thompson Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
1,300,000
+50.0%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
Jason T Thompson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500,000
+42.4%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
Steven B Epstein Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,500,000
+50.0%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
Steven B Epstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500,000
+28.41%
|
$0
$0.1 P/Share
|
Mar 30
2023
|
James R Higgins Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000,000
+41.05%
|
$0
$0.1 P/Share
|
Nov 14
2022
|
Steven B Epstein Director |
BUY
Open market or private purchase
|
Direct |
500,000
+17.99%
|
$0
$0.1 P/Share
|
Nov 14
2022
|
James R Higgins Director |
BUY
Open market or private purchase
|
Direct |
500,000
+4.04%
|
$0
$0.1 P/Share
|
Nov 14
2022
|
Steven G. Johnson President/CEO |
BUY
Open market or private purchase
|
Direct |
500,000
+2.98%
|
$0
$0.1 P/Share
|
Nov 14
2022
|
L. Allen Wheeler Director |
BUY
Open market or private purchase
|
Direct |
500,000
+2.93%
|
$0
$0.1 P/Share
|
Nov 14
2022
|
Jeffrey C Lightcap Director |
BUY
Open market or private purchase
|
Direct |
500,000
+50.0%
|
$0
$0.1 P/Share
|